在心脏保护研究（HPS）和卡维地洛前瞻性随机累积生存研究（CORONA）中氨基末端脑钠肽前体水平的解读 - Suppr

Suppr

超能文献

Interpretation of amino-terminal pro-brain natriuretic peptide levels in the HPS and the CORONA study.

作者信息

Cleland John G F, Squire Iain, Ng Leong

出版信息

J Am Coll Cardiol. 2008 Sep 23;52(13):1104-5. doi: 10.1016/j.jacc.2008.04.070.

DOI:10.1016/j.jacc.2008.04.070

PMID:18848145

Abstract

摘要

相似文献

Interpretation of amino-terminal pro-brain natriuretic peptide levels in the HPS and the CORONA study.

J Am Coll Cardiol. 2008 Sep 23;52(13):1104-5. doi: 10.1016/j.jacc.2008.04.070.

Can natriuretic peptides help identify heart failure patients for whom statins are beneficial?

J Am Coll Cardiol. 2009 Nov 10;54(20):1860-1. doi: 10.1016/j.jacc.2009.06.042.

Rosuvastatin and cardiovascular continuum when time is important.

J Am Coll Cardiol. 2010 Apr 13;55(15):1645-6; author reply 1646. doi: 10.1016/j.jacc.2009.12.031.

Statins and heart failure.

J Am Coll Cardiol. 2010 Apr 13;55(15):1644-5; author reply 1646. doi: 10.1016/j.jacc.2009.11.071.

Evolution of amino-terminal pro-B type natriuretic peptide testing in heart failure.

Drug News Perspect. 2009 Jun;22(5):267-73. doi: 10.1358/dnp.2009.22.5.1378643.

Amino-terminal pro-brain natriuretic peptide to diagnose congestive heart failure in patients with impaired kidney function.

J Am Coll Cardiol. 2006 Sep 5;48(5):1060-1; author reply 1061. doi: 10.1016/j.jacc.2006.06.019. Epub 2006 Aug 17.

Natriuretic peptide-guided therapy for heart failure: ready for "battle" or too "scarred" by the challenges of trial design?

J Am Coll Cardiol. 2009 Dec 29;55(1):61-4. doi: 10.1016/j.jacc.2009.07.055.

Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.

Am Heart J. 2009 Sep;158(3):422-30. doi: 10.1016/j.ahj.2009.06.018. Epub 2009 Jul 9.

Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.

Am J Cardiol. 2009 Jun 15;103(12):1753-9. doi: 10.1016/j.amjcard.2009.02.029.

Clinical significance of N-terminal pro-brain natriuretic peptide.

Chin Med J (Engl). 2004 Nov;117(11):1716-22.

引用本文的文献

Defining Heart Failure Based on Imaging the Heart and Beyond.

Card Fail Rev. 2023 Jun 5;9:e10. doi: 10.15420/cfr.2022.29. eCollection 2023.

Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: implications for future interventions.

Cardiovasc Res. 2023 Feb 3;118(18):3536-3555. doi: 10.1093/cvr/cvac133.

Micronutrient deficiencies in heart failure: Mitochondrial dysfunction as a common pathophysiological mechanism?

J Intern Med. 2022 Jun;291(6):713-731. doi: 10.1111/joim.13456. Epub 2022 Feb 9.

Alirocumab after acute coronary syndrome in patients with a history of heart failure.

Eur Heart J. 2022 Apr 19;43(16):1554-1565. doi: 10.1093/eurheartj/ehab804.

Statin treatment for patients with heart failure.

Nat Rev Cardiol. 2010 May;7(5):249-55. doi: 10.1038/nrcardio.2010.29. Epub 2010 Mar 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Interpretation of amino-terminal pro-brain natriuretic peptide levels in the HPS and the CORONA study.

作者信息

Cleland John G F, Squire Iain, Ng Leong

出版信息

J Am Coll Cardiol. 2008 Sep 23;52(13):1104-5. doi: 10.1016/j.jacc.2008.04.070.

DOI:10.1016/j.jacc.2008.04.070

PMID:18848145

Abstract

摘要

相似文献

Interpretation of amino-terminal pro-brain natriuretic peptide levels in the HPS and the CORONA study.

J Am Coll Cardiol. 2008 Sep 23;52(13):1104-5. doi: 10.1016/j.jacc.2008.04.070.

Can natriuretic peptides help identify heart failure patients for whom statins are beneficial?

J Am Coll Cardiol. 2009 Nov 10;54(20):1860-1. doi: 10.1016/j.jacc.2009.06.042.

Rosuvastatin and cardiovascular continuum when time is important.

J Am Coll Cardiol. 2010 Apr 13;55(15):1645-6; author reply 1646. doi: 10.1016/j.jacc.2009.12.031.

Statins and heart failure.

J Am Coll Cardiol. 2010 Apr 13;55(15):1644-5; author reply 1646. doi: 10.1016/j.jacc.2009.11.071.

Evolution of amino-terminal pro-B type natriuretic peptide testing in heart failure.

Drug News Perspect. 2009 Jun;22(5):267-73. doi: 10.1358/dnp.2009.22.5.1378643.

Amino-terminal pro-brain natriuretic peptide to diagnose congestive heart failure in patients with impaired kidney function.

J Am Coll Cardiol. 2006 Sep 5;48(5):1060-1; author reply 1061. doi: 10.1016/j.jacc.2006.06.019. Epub 2006 Aug 17.

Natriuretic peptide-guided therapy for heart failure: ready for "battle" or too "scarred" by the challenges of trial design?

J Am Coll Cardiol. 2009 Dec 29;55(1):61-4. doi: 10.1016/j.jacc.2009.07.055.

Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.

Am Heart J. 2009 Sep;158(3):422-30. doi: 10.1016/j.ahj.2009.06.018. Epub 2009 Jul 9.

Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.

Am J Cardiol. 2009 Jun 15;103(12):1753-9. doi: 10.1016/j.amjcard.2009.02.029.

Clinical significance of N-terminal pro-brain natriuretic peptide.

Chin Med J (Engl). 2004 Nov;117(11):1716-22.

引用本文的文献

Defining Heart Failure Based on Imaging the Heart and Beyond.

Card Fail Rev. 2023 Jun 5;9:e10. doi: 10.15420/cfr.2022.29. eCollection 2023.

Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: implications for future interventions.

Cardiovasc Res. 2023 Feb 3;118(18):3536-3555. doi: 10.1093/cvr/cvac133.

Micronutrient deficiencies in heart failure: Mitochondrial dysfunction as a common pathophysiological mechanism?

J Intern Med. 2022 Jun;291(6):713-731. doi: 10.1111/joim.13456. Epub 2022 Feb 9.

Alirocumab after acute coronary syndrome in patients with a history of heart failure.

Eur Heart J. 2022 Apr 19;43(16):1554-1565. doi: 10.1093/eurheartj/ehab804.

Statin treatment for patients with heart failure.

Nat Rev Cardiol. 2010 May;7(5):249-55. doi: 10.1038/nrcardio.2010.29. Epub 2010 Mar 16.